Literature DB >> 3720035

The role of intensive dialysis in acute renal failure.

D M Gillum, B S Dixon, M J Yanover, S P Kelleher, M D Shapiro, R G Benedetti, M A Dillingham, M S Paller, J P Goldberg, R C Tomford.   

Abstract

The efficacy of vigorous dialysis in the management of acute renal failure remains controversial. In order to examine the beneficial role of vigorous dialysis, a prospective study was carried out in 34 patients paired by acute renal failure etiology and treated with sufficient dialysis to maintain predialysis blood urea nitrogen and serum creatinine below either 60 and 5 mg/dl (intensive) or 100 and 9 mg/dl, respectively (non-intensive). Serum creatinine was at least 8 mg/dl in all patients prior to random assignment to intensive or non-intensive dialysis. Mean predialysis blood urea nitrogen and serum creatinine, respectively, were 60 +/- 23 and 5.3 +/- 1.5 mg/dl in the intensively dialyzed group and 101 +/- 18 and 9.1 +/- 1.4 mg/dl in the non-intensively dialyzed group (both p less than .001). Predialysis serum bicarbonate and blood pH were lower and serum phosphate higher in the non-intensively dialyzed patients. Daily weight changes, increases in blood urea nitrogen, protein and calorie intakes were similar. While hemorrhagic episodes tended to be more frequent in non-intensively dialyzed patients, overall complication rates were not different between the two groups. Mortality rates, which were 58.8% in the intensive and 47.1% in the non-intensive groups, also were not different. On the other hand, urine output prior to dialysis did influence survival. It is concluded that, within the limits of the study, there is no advantage to intensive dialysis in the management of acute renal failure.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3720035

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  14 in total

Review 1.  The dark side of high-intensity renal replacement therapy of acute kidney injury in critically ill patients.

Authors:  Helmut Schiffl
Journal:  Int Urol Nephrol       Date:  2010-04-10       Impact factor: 2.370

Review 2.  Renal cell therapy and beyond.

Authors:  Joon Ho Song; H David Humes
Journal:  Semin Dial       Date:  2009 Nov-Dec       Impact factor: 3.455

3.  Acute and chronic renal failure in liver transplantation.

Authors:  J McCauley; D H Van Thiel; T E Starzl; J B Puschett
Journal:  Nephron       Date:  1990       Impact factor: 2.847

4.  Continuous arteriovenous haemodialysis and haemofiltration in intensive care acute renal failure patients.

Authors:  A A Alarabi; A Taube; B G Danielson; B Wikström
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

Review 5.  Renal replacement therapy in acute kidney injury.

Authors:  Paul M Palevsky
Journal:  Adv Chronic Kidney Dis       Date:  2013-01       Impact factor: 3.620

6.  Comparison of sustained hemodiafiltration with acetate-free dialysate and continuous venovenous hemodiafiltration for the treatment of critically ill patients with acute kidney injury.

Authors:  Masanori Abe; Noriaki Maruyama; Shiro Matsumoto; Kazuyoshi Okada; Takayuki Fujita; Koichi Matsumoto; Masayoshi Soma
Journal:  Int J Nephrol       Date:  2011-05-14

7.  Acute kidney injury: controversies revisited.

Authors:  Kenneth Yong; Gursharan Dogra; Neil Boudville; Mary Pinder; Wai Lim
Journal:  Int J Nephrol       Date:  2011-04-14

Review 8.  Clinical review: timing of renal replacement therapy.

Authors:  Michael Joannidis; Lui G Forni
Journal:  Crit Care       Date:  2011-06-10       Impact factor: 9.097

9.  Timing of renal replacement therapy initiation for acute kidney injury.

Authors:  Alicia Isabel I Fayad; Daniel G Buamscha; Agustín Ciapponi
Journal:  Cochrane Database Syst Rev       Date:  2018-12-18

10.  Continuous renal replacement therapy for the treatment of acute kidney injury.

Authors:  Woo Kvun Bae; Dae Hun Lim; Ji Min Jeong; Hae Young Jung; Seong Ku Kim; Jeong Woo Park; Eun Hui Bae; Seong Kwon Ma; Soo Wan Kim; Nam Ho Kim; Ki Chul Choi
Journal:  Korean J Intern Med       Date:  2008-06       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.